Clinical Trial Update: Study to Explore the Safety and Efficacy of NT-0796 as an Adjunct to Semaglutide in Participants With Obesity (RESOLVE-2) [Phase 2]

View source ↗

Summary

The document describes a Phase 2 trial (RESOLVE-2) evaluating NT-0796 as an add-on to semaglutide for obesity, with the study currently active but not recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• NT-0796
• semaglutide (semaglutide)

Snippet

Sponsor: NodThera Limited | Conditions: Obesity | Phase 2 | Status: ACTIVE_NOT_RECRUITING